JAMA Cardiology : Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy
Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 15, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Vestibular Schwannoma Treatment, Genetics of Dilated Cardiomyopathy, Folic Acid to Prevent Neural Tube Defects, and more
Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 1, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - August 1, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
AI identifies gene interactions to speed up search for treatment targets
In this episode:00:46 An AI that predicts gene interactionsMapping the network of genes that control cellular processes can be difficult to do when gene-expression data is sparse, such as in rare diseases or those affecting tissues that are hard to clinically sample. To overcome this, a team has developed an artificial intelligence system trained on a large, general dataset, and used it to make predictions about gene interactions in data-limited situations. As a test-case they look at the heart condition cardiomyopathy, and show that the system can identify potential interactions that could represent new therapeutic target...
Source: Nature Podcast - May 31, 2023 Category: Science Authors: Springer Nature Limited Source Type: podcasts
JAMA Cardiology : Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy
Interview with Sharlene M. Day, MD, Rachel Lampert, MD, and Michael J. Ackerman, MD, PhD, authors of Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. Hosted by Robert Bonow, MD. Related Content: Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 17, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Cardiology : Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes
Interview with Aniruddh P. Patel, MD, author of Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality, and M. Benjamin Shoemaker, MD, author of Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes. Hosted by Sadiya Sana Khan, MD, MS. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 11, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Casirivimab and Imdevimab for Early Asymptomatic SARS-CoV-2 Infection, Hypothermia vs Normothermia for Cardiogenic Shock and Extracorporeal Membrane Oxygenation, Familial Idiopathic Dilated Cardiomyopathy, and more
Editor’s Summary by Linda Brubaker, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 1, 2022, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 1, 2022 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Cardiology : Transthyretin Amyloid Cardiomyopathy in Patients With Heart Failure With Preserved Ejection Fraction
Interview with Omar F. AbouEzzeddine, MDCM, MS and Margaret M. Redfield, MD, authors of Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 25, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Do ICDs Have a Role in Nonischemic Cardiomyopathy?
Drs Naveen Pererira, Paul Friedman, and Abhishek Deshmukh discuss how clinical trials have shaped preferences for pacemakers, defibrillators, and optimal medical therapy in the treatment of nonischemic cardiomyopathy. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - June 19, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
Apr 14 Cardiology News
Cardiac arrest care setting, ICDs in patients with nonischemic cardiomyopathy, BP control, readmissions in the elderly with HF, and cardiologists ' pay are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 14, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
JAMA Cardiology : Early Phenotypes and the Influence of Left Ventricular Wall Thickness
Interview with Carolyn Y. Ho, MD, author of The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study, and Jil C. Tardiff, MD, PhD, author of Assessing the Phenotypic Burden of Preclinical Sarcomeric Hypertrophic Cardiomyopathy—New Assessments to Guide Diagnosis and Management (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 22, 2017 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Early Phenotypes and the Influence of Left Ventricular Wall Thickness (JAMA Cardiology)
Interview with Carolyn Y. Ho, MD, author of The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study, and Jil C. Tardiff, MD, PhD, author of Assessing the Phenotypic Burden of Preclinical Sarcomeric Hypertrophic Cardiomyopathy—New Assessments to Guide Diagnosis and Management (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 22, 2017 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Sep 9 Cardiology News
Trends in infective endocarditis, vein-graft intervention, use of OCT in ACS, hypertrophic cardiomyopathy, and electronic health records are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - September 9, 2016 Category: Cardiology Authors: Medscape Source Type: podcasts
Preventing sudden cardiac death in athletes
Sudden cardiac death in athletes aged less than 35 years is the leading cause of medical death in this subgroup, with an estimated incidence of 1 in 50 000 to 1 in 80 000 athletes per year. it is most commonly caused by an underlying genetic heart disorder, such as hypertrophic cardiomyopathy.
In this podcast Christopher Semsarian, professor of medicine at the University of Sydney, joins us to discuss the diagnosis of cardiac changes and prevention of death in this population.
Read the full clinical review:
http://www.bmj.com/content/350/bmj.h1218 (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 20, 2015 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
